NHL: Report: Canadiens minority stake sold at record $2.5B valuation

Date:

Share post:


Michael Andlauer, who bought the Ottawa Senators for $950 million in September, sold his 10 percent minority interest in the Montreal Canadiens at a record $2.5 billion enterprise value, Sportico reported on Wednesday.

The Molson family, which owns a controlling stake in the Canadiens, exercised their option of the first right to buy Andlauer’s stake.

As part of the agreement when he bought the Senators, Andlauer was required to sell his Canadiens stake, which is a record for a standalone NHL team.

The Toronto Maple Leafs were part of an $8 billion valuation this summer, but the stake was in Maple Leaf Sports & Entertainment, which also includes the NBA’s Toronto Raptors and Major League Soccer’s Toronto FC.

Andlauer, the founder and CEO of Andlauer Healthcare Group, had been a minority owner of the Canadiens since 2009, when the Molson family bought the team from George Gillett for $575 million.

Along with the Senators, Andlauer’s group acquired Ottawa’s American Hockey League affiliate, the Belleville Senators, from the estate of Eugene Melnyk. The Melnyk estate kept a 10 percent interest in the club.

The Canadiens and Senators did not respond to requests for comment, while the NHL declined to comment, per the report.

–Field Level Media

spot_img

Related articles

NHL: Maple Leafs host Blackhawks seeking to fix third-period woes

The Toronto Maple Leafs know they must reverse a recent trend of faltering in the third period Tuesday...

NHL: Flyers visit Canadiens aiming to end 3-game skid

The Montreal Canadiens aim to build on a solid performance in their latest game when they host the...

NHL: Wings, Islanders on upward trend entering matchup

Coming off an impressive 4-1-1 road trip, the Detroit Red Wings return home to host the New York...

NHL: After winning road trip, Bruins out to avenge loss to Mammoth

After winning twice during their recent three-game Central Division road trip, the Boston Bruins are now looking for...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.